Ronan Brown is SVP and Head of IQVIA Integrated Global Compliance, where he connects IQVIA’s global partners with high-tech solutions to manage their compliance challenges. He has spent his career supporting healthcare companies through technological transformation, starting in the UK as a CRA for BRI International. He later joined Glaxo Wellcome, where he focused on respiratory studies in several capacities, including project management, medical affairs and market support. As medical technology became increasingly globalized, Ronan moved to Quintiles, eventually leading Minerva, a Quintiles subsidiary based in Glasgow. He joined NovaQuest in 2005, the corporate venture arm of Quintiles, where he focused on identifying promising health solutions in the European biotech market. His specialization in emerging heath technology brought him to San Diego in 2007 to lead business development for NovaQuest on the West Coast. He has since continued to build expertise in how advanced technologies like ML and AI can support safer, more effective health innovation.
Joe Rymsza is VP of Global PV, Regulatory and Quality Technology SolutionsHe has over 25 years of experience in developing, deploying and managing technology solutions in the life sciences industry. In his current role, he oversees IQVIA’s efforts to harness the power of cutting-edge technology for managing regulatory compliance. Prior to IQVIA, Joe was co-CEO of Foresight Group International, a professional services group focused exclusively on drug safety and risk management. His work involved deploying his expertise on every aspect of the pharmaceutical development process, ranging from the selection of technology partners to business process design. Joe has also served as the CEO of Vettro, a mobile technology provider for the life sciences industry, and as Executive Director of professional services firm Cysive.
The life sciences industry will move toward more agile capabilities for regulatory operations and regulators toward an accelerated approval pathway in support of clinical studies, drawing from lessons learned during the pandemic around global collaboration.